> ## Content Index > Fetch the complete content index at: https://www.morningowl.io/llms.txt > Use this file to discover other available public pages before exploring further. # Morning note · September 8, 2026 - URL: https://www.morningowl.io/products/2026-09-08-pro/ - Published: 2026-09-08T12:50:07.000Z - Updated: 2026-09-13T12:20:25.000Z - Author: morningowl - Tags: SYK, BSX, LULU 🦉 Rise and shine. The market kept buzzing all day, and a handful of stocks owned the conversation. How to read each name below: first line = how morningowl sentiment moved since yesterday, second = where it stands now (-100 to +100). ▸ Stryker Corporation (SYK) ▼ Down 10 since yesterday Sentiment now +3 Manufactures surgical equipment, implants, and robotics for hospitals and healthcare facilities. Each group's sentiment and how much it drove today's overall move: News sentiment -94; led today's move. Retail sentiment -52; added to it. News commentary centered on a peer, Boston Scientific, warning it no longer anticipates meeting its 2026 sales and adjusted profit forecasts after a cyberattack disrupted operations. Retail commentary drew the comparison back to Stryker's own earlier breach as a cautionary blueprint, citing its confirmed 12.7% EPS miss and roughly $310M in delayed revenue that fed a \~22% drawdown from pre-attack highs. Both groups leaned cautious, focused on cyber-disruption fallout across the device makers, with retail explicitly favoring waiting for quantified damage over trusting restoration headlines. As of 2026-09-04, Stryker Corp carried a P/E of 31.2, while its last close sat at the 4.8 percentile of its trailing three-month range and the 6.3 percentile of its twelve-month range, down 10.2% over the past month. As of 2026-09-01, coverage leans favorable, with 27 favorable and 7 neutral analysts. It is scheduled to report earnings on 2026-10-28. ▸ Boston Scientific (BSX) ▼ Down 9 since yesterday Sentiment now -16 Manufactures medical devices for diagnosing and treating cardiovascular, gastrointestinal, urological, and neurological conditions. Each group's sentiment and how much it drove today's overall move: News sentiment -85; led today's move. Retail sentiment -43; added to it. News commentary is focused squarely on the disclosure that Boston Scientific no longer anticipates meeting its previously issued third-quarter and full-year 2026 sales and adjusted EPS guidance after a cybersecurity incident disrupted global operations. Retail commentary echoes that same Item 1.05 filing and its flagged "material impact," but centers on how to trade an open liability with financial updates deferred to the Oct 28 call. One retail piece drew a cautionary parallel to Stryker's breach, which confirmed a 12.7% EPS miss. Both groups lean cautious, differing mainly in that retail weighs restored operations against still-unquantified Q3 damage. As of 2026-09-04, Boston Scientific carried a P/E of 18.8, with its last close at the 63.5 percentile of its trailing three-month range and 16.7 of its twelve-month range, down 3.0% over the past month. Over the last 90 days, open-market insider transactions totaled 6 purchases and 0 sales, a net purchase of about $9,486,038 (excludes option exercises and awards). It is scheduled to report earnings on 2026-10-28\. As of 2026-09-01, analyst coverage leans favorable across 38 analysts. ▸ Lululemon Athletica (LULU) ▼ Down 6 since yesterday Sentiment now -41 Designs and retails technical athletic apparel and accessories for yoga, running, and training. Each group's sentiment and how much it drove today's overall move: Analyst sentiment -96; led today's move. News sentiment -96; added to it, on unusually light chatter. Retail sentiment -26. Analyst commentary turned decidedly cautious, with one piece delivering a rating downgrade and another arguing that an 18% crash does not mark a bottom. News commentary, on unusually light chatter, focused on the company's cut to its full-year outlook, citing negative social media buzz that hurt traffic in North America and China alongside revenue that fell 4% year over year to $2.4 billion. Retail commentary was mixed and more divided: some posters braced for further downside toward $105 or lower, while others saw a chance to add on the pullback and floated a near-term move toward $115\. The analyst and news groups broadly align on the deteriorating brand-sentiment story, while the retail group splits between deeper-decline and rebound expectations. As of 2026-09-04, Lululemon Athletica carries a P/E of 8.4, with its last close at the 1.6 percentile of its trailing three-month range and the 0.4 percentile of its 12-month range, down 19.3% over the past month. Over the last 90 days, open-market insider transactions showed 1 purchase and no sales, a net purchase of about $500,384 (excludes option exercises and awards). As of 2026-09-01, analyst opinion leans neutral, based on 2 favorable, 31 neutral, and 7 cautious. That's a wrap for today's chatter, the owls are heading to roost. ☕🦉 See you at dawn. This is not investment advice. morningowl is a publisher, not a registered investment adviser. We may hold positions in any security mentioned. Past performance and historical commentary patterns do not predict future results. Our data and analysis are provided "as is" and may contain inaccuracies; we accept no liability for errors or for any decisions made in reliance on them.